About: http://data.cimple.eu/news-article/7c6b2b42a0b0c18192ee784fd516a5ddbfd8fb74d58c09ddb519b160     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Swiss pharma giant Roche said Monday it is buying US firm GenMark Diagnostics for $1.8 billion (1.5 billion euros). GenMark, based in California, makes molecular tests which can establish the presence of several different pathogens from just one sample, it said. Roche said it is offering $24.05 a share for GenMark, a premium of some 43 percent to its last quoted share price on February 10. "Acquiring GenMark Diagnostics will increase our portfolio of molecular diagnostic (tests)," the company said in a statement. The deal, subject to regulatory approval, should be concluded in the second quarter, it added. noo/oaa/bmm/wdb
schema:headline
  • Roche to buy US firm GenMark Diagnostics for $1.8 bn
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.123 as of May 22 2025


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3241 as of May 22 2025, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software